ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•30 Sep 2018 06:56

Aussie Equities Month in Review (Sept 2018)

Giving Back Reporting Season Gains. In our view, reporting season was relatively solid, with 8% EPS growth achieved in FY18 and another 8%...

Logo
498 Views
Share
•26 Sep 2018 18:37

Aussie Equities Model Portfolio Update

Good outperformance by staying long growth. Our model portfolio has a tilt towards Growth over Value and this has underpinned its solid...

Logo
548 Views
Share
bullish•MSCI ACWI Index
•07 Sep 2018 20:32

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report...

Logo
643 Views
Share
•20 Aug 2018 20:22

Aussie Reporting Season Update: Cracks in the Mirror

Solid Earnings Momentum Hits a Brick Wall. It’s still early days, with only 40% of stocks reporting during the first 2 weeks of reporting season,...

Logo
580 Views
Share
bullish•Telstra Corp
•18 May 2026 06:10

Aussie Shorts [11 May 2026]: Telstra, Woolworths, Lotus Res., Arafura Res., Mcmillan Shakespeare

The largest industry net increase in the past week was A$1.6bn into "Diversified Meals"; the largest industry net decrease was A$129mn out of...

Logo
121 Views
Share
x